Dr. Ernie Lapus Esquivel, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 41 E Post Rd, White Plains, NY 10601 Phone: 914-839-3953 Fax: 914-839-3839 |
Dr. Sam Natarajan, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 222 Westchester Ave, Suite 405, White Plains, NY 10604 Phone: 914-682-6474 Fax: 914-682-6780 |
Dr. Marianne Monahan, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 222 Westchester Ave, White Plains, NY 10604 Phone: 914-683-6474 Fax: 914-683-6780 |
Dr. Iosif Kolbovsky, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 222 Westchester Ave, Suite 405, White Plains, NY 10604 Phone: 914-683-6474 Fax: 914-682-6403 |
Dr. Hany M El Sadr, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3 Barker Ave, 4th Floor Park Avenue Medical Associates Pc, White Plains, NY 10601 Phone: 914-949-1199 Fax: 914-949-1245 |
News Archive
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Columbia University Medical Center researchers have demonstrated that vision loss associated with a form of retinitis pigmentosa (RP) can be slowed dramatically by reprogramming the metabolism of photoreceptors, or light sensors, in the retina.
The United States Department of Justice says that annually around $3 billion is defrauded from seniors. Many of these tricksters use the telephone for their scams. What would not dupe a person with normal mental faculties often takes in seniors. A new study shows that elderly with mild cognitive impairment or early signs of dementia often fall prey to these telephone scams.
The Kansas legislature is considering changes to the state's Medicaid program including exempting long-term care services from some planned reforms.
DiagnoCure Inc., a life sciences company commercializing highâvalue cancer diagnostic tests and delivering lab services, today announced positive initial results of a multi-center clinical study of 241 stage II colon cancer patients, a population categorized as low risk by traditional methods yet with an average recurrence rate of 20%.
› Verified 8 days ago